Novo Nordisk Cash Flow from Operating Activities 2010-2025 | NVO
Novo Nordisk cash flow from operating activities for the twelve months ending March 31, 2025 was $46.381B, a 13.3% increase year-over-year.
- Novo Nordisk annual cash flow from operating activities for 2024 was $17.54B, a 10.92% increase from 2023.
- Novo Nordisk annual cash flow from operating activities for 2023 was $15.813B, a 41.57% increase from 2022.
- Novo Nordisk annual cash flow from operating activities for 2022 was $11.17B, a 27.65% increase from 2021.